Literature DB >> 23150971

Tofacitinib in active ulcerative colitis.

Mario Cottone, Ambrogio Orlando, Claudio Papi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23150971     DOI： 10.1056/NEJMc1211073

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

Review 1.  Targeting interleukins for the treatment of inflammatory bowel disease-what lies beyond anti-TNF therapy?

Authors:  Mairi H McLean; Markus F Neurath; Scott K Durum
Journal:  Inflamm Bowel Dis       Date:  2014-02       Impact factor: 5.325

2.  In vivo administration of a JAK3 inhibitor during acute SIV infection leads to significant increases in viral load during chronic infection.

Authors:  Yoshiaki Takahashi; Siddappa N Byrareddy; Christina Albrecht; Markus Brameier; Lutz Walter; Ann E Mayne; Paul Dunbar; Robert Russo; Dawn M Little; Tara Villinger; Ladawan Khowawisetsut; Kovit Pattanapanyasat; Francois Villinger; Aftab A Ansari
Journal:  PLoS Pathog       Date:  2014-03-06       Impact factor: 6.823

Review 3.  Contribution of STAT3 to Inflammatory and Fibrotic Diseases and Prospects for its Targeting for Treatment.

Authors:  Moses M Kasembeli; Uddalak Bharadwaj; Prema Robinson; David J Tweardy
Journal:  Int J Mol Sci       Date:  2018-08-05       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.